Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

202.19 USD -1.95 (-0.96%)
Streaming Delayed Price Updated: 1:14 PM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
BRIEF-Lilly says provisions included in legislation to repeal Affordable Care Act could adversely affect results
* Provisions included in legislation repealing, replacing affordable care act could have material adverse effect on consolidated results, cash flows Source text - (http://bit.ly/2kIQynP) Further... 
Tags companyNews
From Reuters: Company News
UPDATE 1-CEOs of 16 U.S. companies urge Congress to pass border tax
WASHINGTON, Feb 21 (Reuters) - Chief executive officers of 16 companies, including Boeing Co, Caterpillar Inc and General Electric Co, have urged the U.S. Congress to pass a comprehensive tax code... 
Tags companyNews
From Reuters: Company News
XLV, PFE, MRK, LLY: ETF Outflow Alert
Symbols mentioned in this story: XLV, PFE, MRK, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Export companies tell U.S. Congress to push tax code rewrite
WASHINGTON, Feb 21 (Reuters) - Chief executive officers of 16 companies, including Boeing Co, Caterpillar Inc and General Electric Co, have urged the U.S. Congress to pass a comprehensive tax code... 
Tags companyNews
From Reuters: Company News
Biotechnology: Poised To Head Higher
Biotechnology sector has struggled to overcome regulatory uncertainty. We believe now there is sufficient momentum for Biotechs to breakout and record new 52-week highs compared to a -21% decline in... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Better Buy: Eli Lilly and Company vs. Johnson & Johnson
Tags JNJ LLY
From Motley Fool
After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?
Merck & Co, Inc. (NYSE: MRK) Tuesday reported it was halting its Phase 3 study of Alzheimer's treatment verubecestat in people ... 
Tags LLY General verubecestat
From Benzinga
Border Tax Polarizes U.S Companies As Exporters Take Side With Trump Team
There are two sides to every coin. Even as import-dependent corporations are vociferously opposing President Donald Trump's proposal to ... 
Tags Brian Dodge DeutschePaul Ryan Paul Trussell
From Benzinga
BRIEF-Eli Lilly says additional results from pivotal ra-beam study published in New England Journal of Medicine
* Eli Lilly - additional results from pivotal ra-beam study published in New England Journal of Medicine 
Tags companyNews
From Reuters: Company News
Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next?
Tags RHHBY MRK AXON
From Motley Fool
Merck's Alzheimer's Drug Fails; Are Biogen, Roche, AstraZeneca Next?
Merck delivered a blow late Tuesday to the beta-amyloid theory behind Alzheimer's disease when its drug failed in two clinical trials. 
Tags Technology
From Investor's Business Daily
UPDATE 1-Merck stopping late stage study as another Alzheimer's drug fails
Feb 14 (Reuters) - Merck & Co Inc said on Tuesday it will halt a late-stage trial of an Alzheimer's drug after it was determined that it had no chance of working, marking the latest in a long line of... 
Tags companyNews
From Reuters: Company News
Merck to halt study of mild to moderate Alzheimer's drug
Feb 14 (Reuters) - Merck & Co Inc said it would halt a late-stage trial of its drug in patients with mild to moderate Alzheimer's disease after an external panel pointed to a lack of effectiveness. 
Tags companyNews
From Reuters: Company News
BRIEF-Adocia 2016 revenue down at 22.4 million euros
* 2016 revenue of 22.4 million euros ($23.7 million), compared to 36.9 million euros in 2015 
Tags companyNews
From Reuters: Company News
BRIEF-European Commission approves once-daily olumiant tablets for treatment of rheumatoid arthritis
* European Commission approves once-daily olumiant tablets for treatment of adults with moderate-to-severe active rheumatoid arthritis 
Tags companyNews
From Reuters: Company News
HDV, PG, CSCO, LLY: Large Outflows Detected at ETF
Symbols mentioned in this story: HDV, PG, CSCO, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Is Biogen a Risky Stock?
Tags CELG LLY BIIB
From Motley Fool
Better Buy: AbbVie Inc. vs. Eli Lilly
Tags LLY ABBV
From Motley Fool
BRIEF-Carolyn Bertozzi elected to Lilly board of directors
* Carolyn Bertozzi elected to Lilly board of directors Source text for Eikon: Further company coverage: 
Tags companyNews
From Reuters: Company News
BRIEF-Lilly announces label update for its diabetes drug Trulicity
* Lilly's Trulicity (dulaglutide) label updated to include use in combination with basal insulin for adults with type 2 diabetes 
Tags companyNews
From Reuters: Company News
Stocks Going Ex Dividend the Third Week of February
Here is our latest update on the stock trading technique called 'Buying Dividends,' also commonly referred to as 'Dividend Capture.' 
Tags Stocks / Equities
From Blogs - TalkMarkets
Drug stocks dip after Spicer affirms Trump’s stance on cutting costs
Drug stocks took a hit in afternoon trade after White House press secretary Sean Spicer confirmed that President Trump will look to cut drug prices. 
Tags Pharmaceuticals Industrial Products & Services PFE
From MarketWatch
Q4 Earnings Faring Well For Pharma ETFs
The Q4 earnings season is faring better than the last few years with not only earnings growth on track to reach the highest level in two years but also total earnings set to create a new quarterly... 
Tags Healthcare ETFs
From Blogs - TalkMarkets
Trump's Plan to Lower Drug Costs Is a Fairy Tale
Tags AMGN LLY
From Motley Fool
Trump + Stocks: The Week In Review - Friday, Feb. 3
For most of the week, President Trump's executive order regarding immigration made headlines, but on Friday, the President signed a new executive order dramatically scaling back Dodd-Frank, after... 
Tags Technology Services Stocks / Equities
From Blogs - TalkMarkets
Good News and Bad News for MannKind Corporation
Tags MNKD LLY NVO
From Motley Fool
Biogen Trails Merck, Lilly In Alzheimer's; Hemophilia Spinoff Begins Trading
Biogen will trail Merck, AstraZeneca and Eli Lilly in Alzheimer's disease treatment, an analyst said the day Biogen's hemophilia unit began trading. 
Tags Technology
From Investor's Business Daily
Insiders Bullish on Certain Holdings of FTXH
A look at the weighted underlying holdings of the First Trust Nasdaq Pharmaceuticals ETF (FTXH) shows an impressive 16.1% of holdings on a weighted basis have experienced insider buying within the past... 
Tags ETFs
From ETF Channel
BRIEF-Japan high court rules in Lilly's favor on Alimta patents
* Japan ip high court rules in lilly's favor on alimta vitamin regimen patents 
Tags companyNews
From Reuters: Company News
Eli Lilly’s Fiscal 2016 Earnings: Analyzing The Surprising Results
Eli Lilly has a solid 2.7% dividend yield. And, now that the company’s growth investments are bearing fruit, it has returned to dividend growth. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.